Annual report pursuant to Section 13 and 15(d)

Non-controlling Interest (Details)

v3.19.3.a.u2
Non-controlling Interest (Details) - USD ($)
1 Months Ended 12 Months Ended
Sep. 05, 2018
Sep. 05, 2018
Aug. 31, 2015
Aug. 29, 2015
Aug. 31, 2015
Dec. 31, 2019
Dec. 31, 2018
Noncontrolling Interest [Line Items]              
Equity Method Investment, Ownership Percentage           83.00%  
Net Loss Attributable to Non-controlling Interest           $ (77,000) $ (54,000)
Stockholders' Equity Attributable to Noncontrolling Interest           (2,878,000) (2,909,000)
Related Party Transaction, Expenses from Transactions with Related Party   $ 441,000          
Research and Development Expense $ 102,000         $ 11,083,000 11,844,000
Fair Value Of Shares Issued $ 285,000            
Stock Purchase Agreement [Member]              
Noncontrolling Interest [Line Items]              
Conversion of Stock, Shares Issued     38,572 38,572 38,572    
Research and Development Expense   $ 198,000          
SYN Biomics [Member]              
Noncontrolling Interest [Line Items]              
Equity Method Investment, Ownership Percentage 88.50% 88.50%       83.00%  
Net Loss Attributable to Non-controlling Interest           $ 2,900,000 2,900,000
Noncontrolling Interest, Ownership Percentage by Parent 11.50% 11.50%   8.50%   17.00%  
Additional Number Of Common Stock To Be Issued 2,420,000 2,420,000          
Dr. Pimentels [Member]              
Noncontrolling Interest [Line Items]              
Net Loss Attributable to Non-controlling Interest             54,000,000,000
Dr. Pimentels [Member] | Consolidation, Eliminations [Member]              
Noncontrolling Interest [Line Items]              
Stockholders' Equity Attributable to Noncontrolling Interest             $ 505,000
Cedarssinai Medical Center [Member]              
Noncontrolling Interest [Line Items]              
Number Of Common Stock To Be Issued 50,000 50,000          
Cedarssinai Medical Center [Member] | SYN Biomics [Member]              
Noncontrolling Interest [Line Items]              
Additional Number Of Common Stock To Be Issued 2,420,000 2,420,000